Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription


1 ACS Nano
2 Aging (Albany NY)
1 Am J Cancer Res
1 Asian J Surg
1 Aust N Z J Obstet Gynaecol
1 Biochem Biophys Res Commun
1 Biochim Biophys Acta Rev Cancer
1 Biomed Mater
1 Biomed Pharmacother
2 BMC Cancer
2 BMC Womens Health
1 Cancer Treat Res Commun
1 Cell Rep Med
1 Ceska Gynekol
1 Cureus
1 Enferm Clin (Engl Ed)
2 Environ Toxicol
1 Eur J Public Health
1 Eur Rev Med Pharmacol Sci
1 Exp Cell Res
5 Front Oncol
1 Front Public Health
1 Gene
1 Glob Public Health
1 Gynecol Oncol
1 Health Sci Rep
1 Heliyon
1 Hum Vaccin Immunother
1 Int J Gynaecol Obstet
1 Int J Radiat Oncol Biol Phys
1 J Am Geriatr Soc
2 J Cancer Res Clin Oncol
1 J Cell Mol Med
2 J Gynecol Oncol
1 J Infect Public Health
1 J Med Case Rep
1 J Med Screen
3 J Med Virol
1 J Minim Invasive Gynecol
1 J Obstet Gynaecol
1 J Pathol
1 J Prim Care Community Health
2 JAMA Netw Open
1 JCO Glob Oncol
1 Jpn J Clin Oncol
1 Maturitas
1 Medicine (Baltimore)
1 Mol Carcinog
1 Mol Oncol
2 Pathol Res Pract
1 PLoS One
1 Prev Med
1 Radiat Environ Biophys
1 S Afr Fam Pract (2004)
1 South Asian J Cancer
1 Technol Cancer Res Treat
1 Transl Oncol
1 Value Health
2 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
1 Zhonghua Yu Fang Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    ACS Nano

  1. LIU L, Lei H, Hou G, Zhang L, et al
    Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment.
    ACS Nano. 2024 May 6. doi: 10.1021/acsnano.4c00017.
    PubMed         Abstract available

    Aging (Albany NY)

  2. WANG Y, Han Y, Jin L, Ji L, et al
    A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Aging (Albany NY). 2024;16:7293-7310.
    PubMed         Abstract available

  3. XIONG G, Shan J, Chong Q, Cui Y, et al
    Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma.
    Aging (Albany NY). 2024;16:6898-6920.
    PubMed         Abstract available

    Am J Cancer Res

  4. MA Z, Zhang H, Wang Y, Zhao H, et al
    Circular RNA circIL21R promotes cervical cancer cells proliferation and migration by sponging the miR-1205/PTBP1 axis.
    Am J Cancer Res. 2024;14:1730-1746.
    PubMed         Abstract available

    Asian J Surg

  5. TAN CY, Yang QL, Xu N, Wang HJ, et al
    Small-cell neuroendocrine carcinoma of the cervix: An analysis of 5 cases and literature review.
    Asian J Surg. 2024;47:2508-2509.

    Aust N Z J Obstet Gynaecol

  6. PRESTON M, McBain R, Rajadevan N, Jones A, et al
    Sentinel lymph node detection with indocyanine green and patent blue dye in cervical cancer: A single-centre feasibility study.
    Aust N Z J Obstet Gynaecol. 2024 May 7. doi: 10.1111/ajo.13834.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  7. LIU HT, Zhao Y, Wang HC, Liu QL, et al
    METTL3-mediated m(6)A methylation of SLC38A1 stimulates cervical cancer growth.
    Biochem Biophys Res Commun. 2024;716:150039.
    PubMed         Abstract available

    Biochim Biophys Acta Rev Cancer

  8. GARG P, Krishna M, Subbalakshmi AR, Ramisetty S, et al
    Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189106.
    PubMed         Abstract available

    Biomed Mater

  9. KASHYAP A, Kumari M, Singh A, Mukherjee K, et al
    Current development of theragnostic nanoparticles for women's cancer treatment.
    Biomed Mater. 2024;19.
    PubMed         Abstract available

    Biomed Pharmacother

  10. LIU Q, Chen X, Tan Y, Liu J, et al
    Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review.
    Biomed Pharmacother. 2024;175:116708.
    PubMed         Abstract available

    BMC Cancer

  11. ZHAO A, Pan Y, Gao Y, Zhi Z, et al
    MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
    BMC Cancer. 2024;24:559.
    PubMed         Abstract available

  12. LEI L, Zhang L, Zheng Y, Ma W, et al
    Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    BMC Cancer. 2024;24:575.
    PubMed         Abstract available

    BMC Womens Health

  13. TEKLEHAIMANOT DA, Mekuria AD, Dadi AF, Derseh BT, et al
    Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
    BMC Womens Health. 2024;24:271.
    PubMed         Abstract available

  14. CHEN H, Zhou L, Fong D, Cun Y, et al
    Quality of life and its related-influencing factors in patients with cervical cancer based on the scale QLICP-CE(V2.0).
    BMC Womens Health. 2024;24:277.
    PubMed         Abstract available

    Cancer Treat Res Commun

  15. VEMULA VENKATA VL, Hulikal N, Chowhan AK
    Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer-A prospective study.
    Cancer Treat Res Commun. 2024;39:100816.
    PubMed         Abstract available

    Cell Rep Med

  16. DAI D, Pei Y, Zhu B, Wang D, et al
    Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence.
    Cell Rep Med. 2024 Apr 30:101550. doi: 10.1016/j.xcrm.2024.101550.
    PubMed         Abstract available

    Ceska Gynekol

  17. SANTANA OTANO S, Mendes Melo A, Ferreira Souza B, Souto Morlin J, et al
    Peritumoral stroma and systemic inflammatory response in cervical cancer.
    Ceska Gynekol. 2024;89:95-101.
    PubMed         Abstract available


  18. VANINOV A, Ibraimova D, Sharshenbaeva A, Zhumabekova A, et al
    Trends in the Prevalence and Mortality of Cervical Cancer in the Kyrgyz Republic.
    Cureus. 2024;16:e57863.
    PubMed         Abstract available

    Enferm Clin (Engl Ed)

  19. KIZILTAS S, Topaloglu Oren ED
    Levels of depression and self-esteem in women with cancer of the endometrium and cervix receiving chemotherapy treatment in Turkiye.
    Enferm Clin (Engl Ed). 2024;34:96-107.
    PubMed         Abstract available

    Environ Toxicol

  20. XIONG J, Chen P, He L, Chai X, et al
    Functional mechanism of hypoxia-like conditions mediating resistance to ferroptosis in cervical cancer cells by regulating KDM4A SUMOylation and the SLC7A11/GPX4 pathway.
    Environ Toxicol. 2024 May 10. doi: 10.1002/tox.24304.
    PubMed         Abstract available

  21. LEE CY, Chen PN, Kao SH, Wu HH, et al
    Deoxyshikonin triggers apoptosis in cervical cancer cells through p38 MAPK-mediated caspase activation.
    Environ Toxicol. 2024 May 8. doi: 10.1002/tox.24323.
    PubMed         Abstract available

    Eur J Public Health

  22. PROWSE SR, Brazzelli M, Treweek S
    What factors influence the uptake of bowel, breast and cervical cancer screening? An overview of international research.
    Eur J Public Health. 2024 May 3:ckae073. doi: 10.1093.
    PubMed         Abstract available

    Eur Rev Med Pharmacol Sci

  23. SAHIN G, Duran T, Afsar S, Kebapcilar A, et al
    The antitumoral effect of the esculetin in HeLa cells through endoplasmic reticulum stress.
    Eur Rev Med Pharmacol Sci. 2024;28:3048-3055.
    PubMed         Abstract available

    Exp Cell Res

  24. WEI Y, Yu P, Zouyu Zhao, Sun C, et al
    Cervical Cancer Cell-derived Tie1 Expression Via PI3K/AKT Signaling Pathway Promotes Tumour Progression.
    Exp Cell Res. 2024 May 6:114060. doi: 10.1016/j.yexcr.2024.114060.
    PubMed         Abstract available

    Front Oncol

  25. AGUIAR-ROSAS S, Plancarte-Sanchez R, Hernandez-Porras BC, Garcia-Andreu J, et al
    Pain management in cervical cancer.
    Front Oncol. 2024;14:1371779.
    PubMed         Abstract available

  26. GAO T, Yang Z, Wei L, Tang X, et al
    Prognostic analysis of stage IIIC1p cervical cancer patients.
    Front Oncol. 2024;14:1362281.
    PubMed         Abstract available

  27. TRAN J, Hathaway CL, Broshkevitch CJ, Palanee-Phillips T, et al
    Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic.
    Front Oncol. 2024;14:1382599.
    PubMed         Abstract available

  28. YU X, Dong S, Wang W, Sun X, et al
    Case report: A case of recurrent cervical cancer with bronchial and esophageal metastases presenting with hemoptysis and dysphagia.
    Front Oncol. 2024;14:1375035.
    PubMed         Abstract available

  29. GONZALEZ-RODRIGUEZ JC, Cruz-Valdez A, Madrid-Marina V
    Cervical cancer prevention by vaccination: review.
    Front Oncol. 2024;14:1386167.
    PubMed         Abstract available

    Front Public Health

  30. NARCISSE MR, McElfish PA, Hallgren E, Pierre-Joseph N, et al
    Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.
    Front Public Health. 2024;12:1321253.
    PubMed         Abstract available


  31. ZHANG A, Zheng X, Chen S, Duan G, et al
    In vitro study of HPV18-positive cervical cancer HeLa cells based on CRISPR/Cas13a system.
    Gene. 2024;921:148527.
    PubMed         Abstract available

    Glob Public Health

  32. RAJKHOWA P, Kalyanpur C, K R, Dsouza VS, et al
    Geospatial mapping of public sentiment and infodemic on human papillomavirus vaccination in India: An indication to formulation of strategies for effective implementation.
    Glob Public Health. 2024;19:2348646.
    PubMed         Abstract available

    Gynecol Oncol

  33. CHIBA Y, Kojima Y, Yazaki S, Yoshida H, et al
    Trop-2 expression and the tumor immune microenvironment in cervical cancer.
    Gynecol Oncol. 2024;187:51-57.
    PubMed         Abstract available

    Health Sci Rep

  34. CHEN W, Zhang N, He Z, Li Q, et al
    The efficacy of immune checkpoint inhibitors on low PD-L1 cervical cancer: A meta-analysis.
    Health Sci Rep. 2024;7:e2069.
    PubMed         Abstract available


  35. KUNATOGA A, Mohammadnezhad M, Khan S, Naeem P, et al
    Prevalence and trends of cervical cancer screening among women in Fiji from 2014 to 2018.
    Heliyon. 2024;10:e30220.
    PubMed         Abstract available

    Hum Vaccin Immunother

  36. DVORAK V, Petras M, Dvorak V, Lomozova D, et al
    Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study.
    Hum Vaccin Immunother. 2024;20:2343552.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  37. MWANDACHA N, Dau H, AboMoslim M, Naguti P, et al
    Investigating the healthcare-seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda.
    Int J Gynaecol Obstet. 2024 May 4. doi: 10.1002/ijgo.15577.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  38. ZHU J, Li X, Huang M, Zhu H, et al
    Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multi-center, Randomized, Open-label, Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 3:S0360-3016(24)00611.
    PubMed         Abstract available

    J Am Geriatr Soc

  39. PICKERING AN, Zhao X, Sileanu FE, Lovelace EZ, et al
    Care cascades following low-value cervical cancer screening in dually enrolled Veterans.
    J Am Geriatr Soc. 2024 May 9. doi: 10.1111/jgs.18956.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  40. ZENG F, Guo P, Xia M, He M, et al
    Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    J Cancer Res Clin Oncol. 2024;150:236.
    PubMed         Abstract available

  41. ZHAO N, Li Y, Chen X, Ma J, et al
    Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:233.
    PubMed         Abstract available

    J Cell Mol Med

  42. LU X, Zhang W, Zhang J, Ren D, et al
    EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer.
    J Cell Mol Med. 2024;28:e18361.
    PubMed         Abstract available

    J Gynecol Oncol

  43. HE H, He M, Zhou Q, Tang Y, et al
    Genetic analysis of cervical cancer with lymph node metastasis.
    J Gynecol Oncol. 2024 Apr 29. doi: 10.3802/jgo.2024.
    PubMed         Abstract available

  44. NISHIMURA H, Amano T, Yoneoka Y, Tsuji S, et al
    Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer.
    J Gynecol Oncol. 2024 May 1. doi: 10.3802/jgo.2025.
    PubMed         Abstract available

    J Infect Public Health

  45. SALTA S, Sequeira JP, Lobo J, Sousa A, et al
    Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot.
    J Infect Public Health. 2024;17:1057-1064.
    PubMed         Abstract available

    J Med Case Rep

  46. KOBAYASHI N, Oike T, Ando K, Murata K, et al
    Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    J Med Case Rep. 2024;18:228.
    PubMed         Abstract available

    J Med Screen

  47. WALLER J, Waite F, Marlow L
    Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey.
    J Med Screen. 2024;31:91-98.
    PubMed         Abstract available

    J Med Virol

  48. COSTANZI JM, Stosic MS, Lovestad AH, Ambur OH, et al
    Changes in intrahost genetic diversity according to lesion severity in longitudinal HPV16 samples.
    J Med Virol. 2024;96:e29641.
    PubMed         Abstract available

  49. FAN C, Hu J, Luo T, Dong B, et al
    Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    J Med Virol. 2024;96:e29521.
    PubMed         Abstract available

  50. PASQUIER C, Raymond S, Carcenac R, Demmou S, et al
    HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
    J Med Virol. 2024;96:e29652.
    PubMed         Abstract available

    J Minim Invasive Gynecol

  51. HA K, Sheets K, Kedar R, Gooden C, et al
    Primary Cervical Lymphoma Mimicking Deep Endometriosis.
    J Minim Invasive Gynecol. 2024;31:357-359.

    J Obstet Gynaecol

  52. NEWTON C, Graham R, Liberale V, Burnell M, et al
    Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    J Obstet Gynaecol. 2024;44:2344529.
    PubMed         Abstract available

    J Pathol

  53. LIN LH, Howitt BE, Kolin DL
    From morphology to methylome: epigenetic studies of Mullerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma(dagger).
    J Pathol. 2024;263:135-138.
    PubMed         Abstract available

    J Prim Care Community Health

  54. EHMAN KM, Jenkins GD, Grimm JA, Cammack TL, et al
    Primary Human Papillomavirus Test Uptake and Cervical Cancer Screening Trends in the Midwest, United States.
    J Prim Care Community Health. 2024;15:21501319241251934.
    PubMed         Abstract available

    JAMA Netw Open

  55. BAUMANN K, Matzke H, Peterson CE, Geller S, et al
    Sexual Orientation and Cervical Cancer Screening Among Cisgender Women.
    JAMA Netw Open. 2024;7:e248886.
    PubMed         Abstract available

  56. FISHER A, Long JR, Chor J
    Closing the Cervical Cancer Screening Gap-Reaching Sexual and Gender Diverse Populations.
    JAMA Netw Open. 2024;7:e248855.

    JCO Glob Oncol

  57. SHASTRI SS, McNeill LH, Shete S
    Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target Among Low-Income Non-Hispanic Black and Hispanic Women.
    JCO Glob Oncol. 2024;10:e2400005.
    PubMed         Abstract available

    Jpn J Clin Oncol

  58. NISHIO H, Matsuda R, Iwata T, Yamagami W, et al
    Gastric-type adenocarcinoma of the uterine cervix: clinical features and future directions.
    Jpn J Clin Oncol. 2024;54:516-520.
    PubMed         Abstract available


  59. PENG X, Wang B, Li X, Li Y, et al
    Correlates of sexual and reproductive health service utilization among older adults in China: Findings from the sexual well-being (SWELL) study.
    Maturitas. 2024;184:107965.
    PubMed         Abstract available

    Medicine (Baltimore)

  60. ZHU Z, Lu J
    Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
    Medicine (Baltimore). 2024;103:e38116.
    PubMed         Abstract available

    Mol Carcinog

  61. ZHANG W, Wang H, Chen S, Fan X, et al
    Reactivation of methylation-silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway.
    Mol Carcinog. 2024 May 7. doi: 10.1002/mc.23728.
    PubMed         Abstract available

    Mol Oncol

  62. SINGH AK, Walavalkar K, Tavernari D, Ciriello G, et al
    Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers.
    Mol Oncol. 2024;18:1189-1208.
    PubMed         Abstract available

    Pathol Res Pract

  63. LORENSET LC, Percicote AP, Munhos SHO, Zanine RM, et al
    Reevaluation of negative cervical conizations: Frequency, diagnostic errors, risk factors and management.
    Pathol Res Pract. 2024;257:155283.
    PubMed         Abstract available

  64. FELICELLI C, Smith SH, Griffin B, Grubs A, et al
    The Silva pattern-based classification for HPV-associated endocervical adenocarcinoma: A single institution concordance study of trainees and gynecologic pathologists.
    Pathol Res Pract. 2024;257:155311.
    PubMed         Abstract available

    PLoS One

  65. WANG QL, Gong C, Meng XY, Fu M, et al
    TPP1 is associated with risk of advanced precursors and cervical cancer survival.
    PLoS One. 2024;19:e0298118.
    PubMed         Abstract available

    Prev Med

  66. MOOSES K, Savrova A, Pajusalu M, Oja M, et al
    Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Prev Med. 2024;183:107982.
    PubMed         Abstract available

    Radiat Environ Biophys

  67. MISHRA R, Singh S, Patel G, Mandal A, et al
    Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations.
    Radiat Environ Biophys. 2024 May 9. doi: 10.1007/s00411-024-01069.
    PubMed         Abstract available

    S Afr Fam Pract (2004)

  68. ADAMS RA, Visser C, Dreyer G, Snyman L, et al
    Sociodemographics, behaviour and knowledge of first South African HPV-vaccine recipients.
    S Afr Fam Pract (2004). 2024;66:e1-e6.
    PubMed         Abstract available

    South Asian J Cancer

  69. NESSA A, Islam T, Noor-E-Ferdousi NE, Sultana A, et al
    Staging and Management of Cervical Cancer at the Colposcopy Clinic of Bangabandhu Sheikh Sheikh Mujib Medical University (BSMMU), Bangladesh.
    South Asian J Cancer. 2024;13:17-26.
    PubMed         Abstract available

    Technol Cancer Res Treat

  70. ZHANG W, Yu H, Xiu Y, Meng F, et al
    Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
    Technol Cancer Res Treat. 2024;23:15330338241254075.
    PubMed         Abstract available

    Transl Oncol

  71. LIU S, Wang Z, Hu L, Ye C, et al
    Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer.
    Transl Oncol. 2024;45:101982.
    PubMed         Abstract available

    Value Health

  72. AUGUSTOVSKI F, Argento F, Alcaraz A, Garcia Marti S, et al
    Toward the Implementation of a Value Framework for Diagnostic Technologies: Operationalization, Piloting, and Validation in Latin America.
    Value Health. 2024;27:570-577.
    PubMed         Abstract available

    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  73. XU Y, Gao L, Yang J, Wang J, et al
    [Knockdown mitochondrial transcription factor A (TFAM) inhibits autophagy, proliferation, invasion and migration in human cervical cancer and osteosarcoma cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:311-318.
    PubMed         Abstract available

  74. PENG Q, Li Y, Li J, Yao X, et al
    [Research progress on the differences between T and B cell responses to three different forms of human papilloma virus (HPV) vaccination].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:378-382.
    PubMed         Abstract available

    Zhonghua Yu Fang Yi Xue Za Zhi

  75. [Expert recommendation for real-world study on the application of human papillomavirus vaccine in the Yangtze River Delta region].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:577-587.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.